OpenAI releases MedChemBench: GPT-6.2 Astra scores 84.5% but nails only half the key drug-design calls

rohanpaul_ai · x · 2026-11-21

OpenAI introduced MedChemBench, a benchmark testing whether AI models can read molecular structures, interpret experimental evidence, and decide which compounds to synthesize next.

Takeaway: AI understands medicinal chemistry well, but the key judgment calls still lag behind human chemists.

Related event: OpenAI Launches MedChemBench for AI Drug Chemistry Reasoning(4 posts)→

Original post →

More from Research

Research channel →